---
figid: PMC4520755__nihms704101f1
figlink: /pmc/articles/PMC4520755/figure/F1/
number: Figure 1
caption: 'The canonical Notch signalling pathway and relevant pharmacological inhibitors
  under development in cancer. DLL1, DLL3 and DLL4, and Jagged ligands (JAG1 and JAG2)
  expressed on the cell surface can induce signalling in adjacent cells expressing
  their cognate receptors Notch1–4. Ligand binding promotes sequential cleavage of
  the Notch receptors by ADAM/TACE enzymes (S2 cleavage) and then γ-secretase (S3
  cleavage), resulting in release the NICD, which interacts with transcriptional regulators
  in the nucleus to instigate a Notch gene-expression profile. Notch target genes,
  in turn, regulate pivotal cell-fate choices, including differentiation, cell-cycle
  progression and survival. The final phenotypic effect is dependent on the specific
  signalling context, paralogue, ligand and dosage. Under many conditions, and in
  several types of cancer stem-like cells, Notch signalling can delay differentiation,
  and maintain proliferative and survival potential. Potential therapeutic inhibitors
  of targets involved in the Notch signalling include soluble decoy receptors, mAbs
  targeting the Notch ligands or receptors in the extracellular space, and small-molecules
  or mAb inhibitors targeting the γ-secretase complex. Abbreviations: ADAM, a disintegrin
  and metalloproteinase; APH-1/2, anterior pharynx-defective-1/2; CSL, CBF1/Su(H)/Lag-1;
  DLL, delta-like ligand; HAT, histone acetyltransferase; HES, hairy and enhancer
  of split-1; JAG1, Jagged-1; JAG2, Jagged-2; mAb, monoclonal antibody; MAML1, Mastermind-like
  1; NICD, Notch intracellular domain; NRARP, Notch-regulated ankyrin-repeated protein;
  SKIP, ski-interacting protein; TACE, TNF-α-converting enzyme (also known as ADAM17).'
pmcid: PMC4520755
papertitle: 'Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical
  update.'
reftext: Naoko Takebe, et al. Nat Rev Clin Oncol. ;12(8):445-464.
pmc_ranked_result_index: '31297'
pathway_score: 0.9747989
filename: nihms704101f1.jpg
figtitle: Canonical Notch signalling pathway and relevant pharmacological inhibitors
  under development in cancer
year: ''
organisms: Homo sapiens
ndex: 17fd65ed-deb9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4520755__nihms704101f1.html
  '@type': Dataset
  description: 'The canonical Notch signalling pathway and relevant pharmacological
    inhibitors under development in cancer. DLL1, DLL3 and DLL4, and Jagged ligands
    (JAG1 and JAG2) expressed on the cell surface can induce signalling in adjacent
    cells expressing their cognate receptors Notch1–4. Ligand binding promotes sequential
    cleavage of the Notch receptors by ADAM/TACE enzymes (S2 cleavage) and then γ-secretase
    (S3 cleavage), resulting in release the NICD, which interacts with transcriptional
    regulators in the nucleus to instigate a Notch gene-expression profile. Notch
    target genes, in turn, regulate pivotal cell-fate choices, including differentiation,
    cell-cycle progression and survival. The final phenotypic effect is dependent
    on the specific signalling context, paralogue, ligand and dosage. Under many conditions,
    and in several types of cancer stem-like cells, Notch signalling can delay differentiation,
    and maintain proliferative and survival potential. Potential therapeutic inhibitors
    of targets involved in the Notch signalling include soluble decoy receptors, mAbs
    targeting the Notch ligands or receptors in the extracellular space, and small-molecules
    or mAb inhibitors targeting the γ-secretase complex. Abbreviations: ADAM, a disintegrin
    and metalloproteinase; APH-1/2, anterior pharynx-defective-1/2; CSL, CBF1/Su(H)/Lag-1;
    DLL, delta-like ligand; HAT, histone acetyltransferase; HES, hairy and enhancer
    of split-1; JAG1, Jagged-1; JAG2, Jagged-2; mAb, monoclonal antibody; MAML1, Mastermind-like
    1; NICD, Notch intracellular domain; NRARP, Notch-regulated ankyrin-repeated protein;
    SKIP, ski-interacting protein; TACE, TNF-α-converting enzyme (also known as ADAM17).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDK5
  - CCND3
  - CDK12
  - CDK14
  - ADAM17
  - HES7
  - CDK7
  - DLL4
  - DLL3
  - CDK6
  - HES1
  - CDK1
  - HES2
  - HES6
  - CDK17
  - CDK18
  - CDK3
  - CDK4
  - NOTCH2
  - NOTCH3
  - NOTCH1
  - CDK8
  - CDK9
  - CDK19
  - CDK20
  - HES4
  - CDK11B
  - CDKL1
  - CDK2
  - TCEA1
  - MYC
  - NOTCH4
  - ERBB2
  - CDK15
  - CDKL5
  - CDK11A
  - CDK10
  - NRARP
  - CDKL4
  - CDKL3
  - CDK16
  - JAG1
  - DLL1
  - HES3
  - CDK13
  - HES5
  - CSHL1
  - JAG2
  - MAML1
  - CDKN1A
  - CDKL2
genes:
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK5
  entrez: '1020'
- word: (CCND3)
  symbol: CCND3
  source: hgnc_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK12
  entrez: '51755'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK14
  entrez: '5218'
- word: ADAM/TACE
  symbol: TACE
  source: hgnc_prev_symbol
  hgnc_symbol: ADAM17
  entrez: '6868'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES7
  entrez: '84667'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK7
  entrez: '1022'
- word: (DLL1,DLL3,DLL4)
  symbol: DLL4
  source: hgnc_symbol
  hgnc_symbol: DLL4
  entrez: '54567'
- word: DLL3,
  symbol: DLL3
  source: hgnc_symbol
  hgnc_symbol: DLL3
  entrez: '10683'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES1
  entrez: '3280'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK1
  entrez: '983'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES2
  entrez: '54626'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES6
  entrez: '55502'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK17
  entrez: '5128'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK18
  entrez: '5129'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK3
  entrez: '1018'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK8
  entrez: '1024'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK19
  entrez: '23097'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK20
  entrez: '23552'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES4
  entrez: '57801'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11B
  entrez: '984'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL1
  entrez: '8814'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: S2
  symbol: SII
  source: hgnc_alias_symbol
  hgnc_symbol: TCEA1
  entrez: '6917'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Notch
  symbol: Notch
  source: bioentities_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK15
  entrez: '65061'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL5
  entrez: '6792'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK11A
  entrez: '728642'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK10
  entrez: '8558'
- word: NRARP
  symbol: NRARP
  source: hgnc_symbol
  hgnc_symbol: NRARP
  entrez: '441478'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL4
  entrez: '344387'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL3
  entrez: '51265'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK16
  entrez: '5127'
- word: (JAG1,
  symbol: JAG1
  source: hgnc_symbol
  hgnc_symbol: JAG1
  entrez: '182'
- word: (DLL1,
  symbol: DLL1
  source: hgnc_symbol
  hgnc_symbol: DLL1
  entrez: '28514'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES3
  entrez: '390992'
- word: Notch1-4
  symbol: NOTCH1
  source: hgnc_symbol
  hgnc_symbol: NOTCH1
  entrez: '4851'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDK13
  entrez: '8621'
- word: HES
  symbol: HES
  source: bioentities_symbol
  hgnc_symbol: HES5
  entrez: '388585'
- word: Notch1-4
  symbol: NOTCH3
  source: hgnc_symbol
  hgnc_symbol: NOTCH3
  entrez: '4854'
- word: CSL
  symbol: CSL
  source: hgnc_alias_symbol
  hgnc_symbol: CSHL1
  entrez: '1444'
- word: JAG2)
  symbol: JAG2
  source: hgnc_symbol
  hgnc_symbol: JAG2
  entrez: '3714'
- word: MAML1
  symbol: MAML1
  source: hgnc_symbol
  hgnc_symbol: MAML1
  entrez: '9794'
- word: (CDKN1A)
  symbol: CDKN1A
  source: hgnc_symbol
  hgnc_symbol: CDKN1A
  entrez: '1026'
- word: Notch1-4
  symbol: NOTCH2
  source: hgnc_symbol
  hgnc_symbol: NOTCH2
  entrez: '4853'
- word: Notch1-4
  symbol: NOTCH4
  source: hgnc_symbol
  hgnc_symbol: NOTCH4
  entrez: '4855'
- word: CDK
  symbol: CDK
  source: bioentities_symbol
  hgnc_symbol: CDKL2
  entrez: '8999'
chemicals: []
diseases: []
---
